Diabetes Care 2011;34:14811486 [DOI] [PMC free article] [PubMed] [Google Scholar] 30
This will open up its use beyond diabetes management and more people will be able to benefit from its weight loss property
Like the other type 2 diabetes medications, Mounjaro lowers blood sugar levels, increases insulin sensitivity, slows the digestive system and decreases appetite
GLP-3, a GIP, GLP-1 and Glucagon Receptor Agonist, for People with Type 2 Diabetes: A Randomised, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Phase 2 Trial Conducted in the USA, Rosenstock J
This is particularly salutary for individualities who struggle with shifting blood sugar situations, as it provides further harmonious control
[PUBMED Abstract] Agarwal N, Azad AA, Carles J, et al.: Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial